Suspicious Order Monitoring (SOM)

Suspicious Order Monitoring (SOM) is the DEA-required program controlled substance manufacturers and distributors must operate to identify, halt, and report suspicious orders under 21 USC 832 and the implementing regulations at 21 CFR 1301.74(b). A suspicious order is one of unusual size, deviating substantially from a normal pattern, or unusual frequency. SOM failures have driven DEA enforcement actions and substantial civil and criminal exposure across the opioid distribution supply chain.

How Suspicious Order Monitoring works

Manufacturers and distributors must design SOM systems that identify orders meeting the regulatory criteria (unusual size, pattern, or frequency), halt shipment of those orders until the suspicious-order determination is resolved, and report unresolved suspicious orders to DEA. The 2018 SUPPORT Act codified the SOM obligation more explicitly at 21 USC 832, including the duty to identify and halt before shipping. DEA inspection focus on SOM compliance has intensified since 2018, with multiple distributors facing significant civil and criminal exposure for SOM program inadequacy.

The substantive SOM analysis covers: the order's size relative to the customer's documented order history; the order's frequency relative to expected patterns; the order's deviation from documented therapeutic-need indicators; and the customer's overall risk profile based on geography, customer type, controlled-substance mix, and other due-diligence indicators. Documentation of the suspicious-order analysis and the resolution decision is central to SOM defense.

When Suspicious Order Monitoring applies

SOM applies to every manufacturer and distributor of controlled substances at the Schedule II through Schedule V levels. Retail pharmacies receive controlled substance shipments from distributors but do not operate SOM programs in the same regulatory sense, though pharmacies are subject to parallel due diligence obligations under the corresponding responsibility doctrine. DEA Diversion Investigators inspect SOM programs as part of routine inspection cycles and in connection with specific investigations.

The distributor's exposure under SOM

Civil penalty exposure for SOM violations under 21 USC 842(c)(1) can reach $25,000 per violation, with violations measured per suspicious order not reported and per day of continuing failure. Criminal exposure attaches where the SOM program inadequacy supports a knowing or willful theory of distribution to prohibited purposes. DEA registration consequences include suspension, revocation, or imposition of corrective action requirements. The defense framework focuses on the SOM program documentation, the analytical record on disputed orders, customer due diligence files, and the systems and controls evidence that demonstrates a reasonable SOM compliance posture.

Related terms

• DEA Order to Show Cause The DEA administrative proceeding that frequently follows SOM compliance findings.
• Immediate Suspension Order The DEA emergency action that can stop distribution before the SOM matter is fully adjudicated.
• Inventory reconciliation The parallel audit technique applied to controlled substance distribution.
• Subpoena The DEA Diversion Investigator's compulsory process used in SOM investigations.

See also

• Practice area
  DEA Defense

  The full DEA defense framework spanning SOM compliance, OSC, ISO, and parallel criminal coordination.

• Practice area
  DEA Inspections Defense

  Defense framework for DEA inspections that include SOM program review.